Resources by Therapeutic Area
Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximab
The objective of this study was to examine the assay formats used to detect anti-drug antibodies (ADA) in clinical studies of the anti-TNF monoclonal antibodies adalimumab and infliximab in chronic inflammatory disease and their potential impact on pharmacokinetic and clinical outcomes.
This report describes a novel method for isolating and detecting individual enzyme molecules using polymer arrays of picoliter microwells.
The Quanterix SR-X Ultra-Sensitive Biomarker Detection System is the latest instrument powered by Simoa® technology offering researchers access to ultra-sensitive biomarker detection capabilities in a compact affordable system. Join us to learn more!
Effects of Canagliflozin Versus Glimepiride on Adipokines and Inflammatory Biomarkers in Type 2 Diabetes
Type 2 diabetes and obesity are pro-inflammatory states associated with increased risk of cardiovascular disease.
Ralph McDade explains the importance of using ultra-sensitive immunoassays from Quanterix